nodes	percent_of_prediction	percent_of_DWPC	metapath
Metipranolol—Lacrimation—Irinotecan—colon cancer	0.0429	0.0448	CcSEcCtD
Metipranolol—Lacrimation—Fluorouracil—colon cancer	0.041	0.0429	CcSEcCtD
Metipranolol—Blepharitis—Fluorouracil—colon cancer	0.0392	0.041	CcSEcCtD
Metipranolol—Lacrimation increased—Irinotecan—colon cancer	0.0273	0.0286	CcSEcCtD
Metipranolol—Lacrimation increased—Fluorouracil—colon cancer	0.0262	0.0274	CcSEcCtD
Metipranolol—Photophobia—Fluorouracil—colon cancer	0.0227	0.0237	CcSEcCtD
Metipranolol—Lacrimation increased—Capecitabine—colon cancer	0.0183	0.0191	CcSEcCtD
Metipranolol—Angina pectoris—Irinotecan—colon cancer	0.0154	0.0161	CcSEcCtD
Metipranolol—Angina pectoris—Fluorouracil—colon cancer	0.0147	0.0154	CcSEcCtD
Metipranolol—Abnormal vision—Capecitabine—colon cancer	0.0147	0.0154	CcSEcCtD
Metipranolol—Acute coronary syndrome—Vincristine—colon cancer	0.0143	0.0149	CcSEcCtD
Metipranolol—Myocardial infarction—Vincristine—colon cancer	0.0142	0.0148	CcSEcCtD
Metipranolol—Atenolol—ABCB1—colon cancer	0.0139	0.323	CrCbGaD
Metipranolol—Acute coronary syndrome—Irinotecan—colon cancer	0.0139	0.0145	CcSEcCtD
Metipranolol—Myocardial infarction—Irinotecan—colon cancer	0.0138	0.0144	CcSEcCtD
Metipranolol—Acute coronary syndrome—Fluorouracil—colon cancer	0.0133	0.0139	CcSEcCtD
Metipranolol—Myocardial infarction—Fluorouracil—colon cancer	0.0132	0.0138	CcSEcCtD
Metipranolol—Conjunctivitis—Fluorouracil—colon cancer	0.0131	0.0137	CcSEcCtD
Metipranolol—Atrial fibrillation—Capecitabine—colon cancer	0.0129	0.0135	CcSEcCtD
Metipranolol—Bradycardia—Irinotecan—colon cancer	0.0129	0.0135	CcSEcCtD
Metipranolol—Acebutolol—ABCB1—colon cancer	0.0128	0.298	CrCbGaD
Metipranolol—Epistaxis—Fluorouracil—colon cancer	0.0127	0.0133	CcSEcCtD
Metipranolol—Rhinitis—Irinotecan—colon cancer	0.0127	0.0133	CcSEcCtD
Metipranolol—Arthritis—Capecitabine—colon cancer	0.0126	0.0132	CcSEcCtD
Metipranolol—Visual impairment—Irinotecan—colon cancer	0.0122	0.0127	CcSEcCtD
Metipranolol—Rhinitis—Fluorouracil—colon cancer	0.0121	0.0127	CcSEcCtD
Metipranolol—Metoprolol—ABCB1—colon cancer	0.0108	0.252	CrCbGaD
Metipranolol—Angina pectoris—Capecitabine—colon cancer	0.0103	0.0108	CcSEcCtD
Metipranolol—Bronchitis—Capecitabine—colon cancer	0.0102	0.0106	CcSEcCtD
Metipranolol—Vision blurred—Fluorouracil—colon cancer	0.00994	0.0104	CcSEcCtD
Metipranolol—Hypertension—Vincristine—colon cancer	0.00976	0.0102	CcSEcCtD
Metipranolol—Myalgia—Vincristine—colon cancer	0.00963	0.0101	CcSEcCtD
Metipranolol—Cough—Irinotecan—colon cancer	0.00961	0.01	CcSEcCtD
Metipranolol—Hypertension—Irinotecan—colon cancer	0.00951	0.00994	CcSEcCtD
Metipranolol—Acute coronary syndrome—Capecitabine—colon cancer	0.0093	0.00972	CcSEcCtD
Metipranolol—Discomfort—Irinotecan—colon cancer	0.00927	0.00968	CcSEcCtD
Metipranolol—Myocardial infarction—Capecitabine—colon cancer	0.00925	0.00966	CcSEcCtD
Metipranolol—Oedema—Vincristine—colon cancer	0.00923	0.00965	CcSEcCtD
Metipranolol—Conjunctivitis—Capecitabine—colon cancer	0.00917	0.00958	CcSEcCtD
Metipranolol—Oedema—Irinotecan—colon cancer	0.00899	0.00939	CcSEcCtD
Metipranolol—Myalgia—Fluorouracil—colon cancer	0.00898	0.00939	CcSEcCtD
Metipranolol—Epistaxis—Capecitabine—colon cancer	0.0089	0.0093	CcSEcCtD
Metipranolol—Discomfort—Fluorouracil—colon cancer	0.00887	0.00927	CcSEcCtD
Metipranolol—Bradycardia—Capecitabine—colon cancer	0.00862	0.00901	CcSEcCtD
Metipranolol—Oedema—Fluorouracil—colon cancer	0.00861	0.009	CcSEcCtD
Metipranolol—Rhinitis—Capecitabine—colon cancer	0.00849	0.00887	CcSEcCtD
Metipranolol—Musculoskeletal discomfort—Vincristine—colon cancer	0.00841	0.00879	CcSEcCtD
Metipranolol—Visual impairment—Capecitabine—colon cancer	0.00816	0.00853	CcSEcCtD
Metipranolol—Dyspnoea—Irinotecan—colon cancer	0.00801	0.00838	CcSEcCtD
Metipranolol—Somnolence—Irinotecan—colon cancer	0.00799	0.00835	CcSEcCtD
Metipranolol—Musculoskeletal discomfort—Fluorouracil—colon cancer	0.00784	0.0082	CcSEcCtD
Metipranolol—Dyspnoea—Fluorouracil—colon cancer	0.00768	0.00802	CcSEcCtD
Metipranolol—Somnolence—Fluorouracil—colon cancer	0.00765	0.008	CcSEcCtD
Metipranolol—Vision blurred—Capecitabine—colon cancer	0.00695	0.00726	CcSEcCtD
Metipranolol—Conjunctivitis—Methotrexate—colon cancer	0.00683	0.00713	CcSEcCtD
Metipranolol—Hypersensitivity—Vincristine—colon cancer	0.0068	0.00711	CcSEcCtD
Metipranolol—Epistaxis—Methotrexate—colon cancer	0.00662	0.00692	CcSEcCtD
Metipranolol—Hypersensitivity—Irinotecan—colon cancer	0.00662	0.00692	CcSEcCtD
Metipranolol—Asthenia—Vincristine—colon cancer	0.00662	0.00692	CcSEcCtD
Metipranolol—Palpitations—Capecitabine—colon cancer	0.00651	0.00681	CcSEcCtD
Metipranolol—Asthenia—Irinotecan—colon cancer	0.00645	0.00674	CcSEcCtD
Metipranolol—Cough—Capecitabine—colon cancer	0.00643	0.00672	CcSEcCtD
Metipranolol—Hypertension—Capecitabine—colon cancer	0.00636	0.00665	CcSEcCtD
Metipranolol—Hypersensitivity—Fluorouracil—colon cancer	0.00634	0.00663	CcSEcCtD
Metipranolol—Myalgia—Capecitabine—colon cancer	0.00628	0.00656	CcSEcCtD
Metipranolol—Anxiety—Capecitabine—colon cancer	0.00625	0.00654	CcSEcCtD
Metipranolol—Discomfort—Capecitabine—colon cancer	0.0062	0.00648	CcSEcCtD
Metipranolol—Dizziness—Vincristine—colon cancer	0.0061	0.00638	CcSEcCtD
Metipranolol—Visual impairment—Methotrexate—colon cancer	0.00608	0.00635	CcSEcCtD
Metipranolol—Oedema—Capecitabine—colon cancer	0.00602	0.00629	CcSEcCtD
Metipranolol—Dizziness—Irinotecan—colon cancer	0.00594	0.00621	CcSEcCtD
Metipranolol—Rash—Vincristine—colon cancer	0.00582	0.00608	CcSEcCtD
Metipranolol—Dermatitis—Vincristine—colon cancer	0.00581	0.00608	CcSEcCtD
Metipranolol—Headache—Vincristine—colon cancer	0.00578	0.00604	CcSEcCtD
Metipranolol—Dizziness—Fluorouracil—colon cancer	0.00569	0.00595	CcSEcCtD
Metipranolol—Rash—Irinotecan—colon cancer	0.00567	0.00592	CcSEcCtD
Metipranolol—Dermatitis—Irinotecan—colon cancer	0.00566	0.00592	CcSEcCtD
Metipranolol—Headache—Irinotecan—colon cancer	0.00563	0.00589	CcSEcCtD
Metipranolol—Nausea—Vincristine—colon cancer	0.00548	0.00573	CcSEcCtD
Metipranolol—Musculoskeletal discomfort—Capecitabine—colon cancer	0.00548	0.00573	CcSEcCtD
Metipranolol—Propranolol—ABCB1—colon cancer	0.00547	0.127	CrCbGaD
Metipranolol—Rash—Fluorouracil—colon cancer	0.00543	0.00567	CcSEcCtD
Metipranolol—Dermatitis—Fluorouracil—colon cancer	0.00542	0.00567	CcSEcCtD
Metipranolol—Headache—Fluorouracil—colon cancer	0.00539	0.00564	CcSEcCtD
Metipranolol—Dyspnoea—Capecitabine—colon cancer	0.00536	0.00561	CcSEcCtD
Metipranolol—Nausea—Irinotecan—colon cancer	0.00534	0.00558	CcSEcCtD
Metipranolol—Vision blurred—Methotrexate—colon cancer	0.00517	0.0054	CcSEcCtD
Metipranolol—Nausea—Fluorouracil—colon cancer	0.00511	0.00534	CcSEcCtD
Metipranolol—Cough—Methotrexate—colon cancer	0.00479	0.005	CcSEcCtD
Metipranolol—Myalgia—Methotrexate—colon cancer	0.00467	0.00488	CcSEcCtD
Metipranolol—Discomfort—Methotrexate—colon cancer	0.00462	0.00482	CcSEcCtD
Metipranolol—Hypersensitivity—Capecitabine—colon cancer	0.00443	0.00463	CcSEcCtD
Metipranolol—Asthenia—Capecitabine—colon cancer	0.00432	0.00451	CcSEcCtD
Metipranolol—Musculoskeletal discomfort—Methotrexate—colon cancer	0.00408	0.00426	CcSEcCtD
Metipranolol—Dyspnoea—Methotrexate—colon cancer	0.00399	0.00417	CcSEcCtD
Metipranolol—Somnolence—Methotrexate—colon cancer	0.00398	0.00416	CcSEcCtD
Metipranolol—Dizziness—Capecitabine—colon cancer	0.00398	0.00416	CcSEcCtD
Metipranolol—Rash—Capecitabine—colon cancer	0.00379	0.00396	CcSEcCtD
Metipranolol—Dermatitis—Capecitabine—colon cancer	0.00379	0.00396	CcSEcCtD
Metipranolol—Headache—Capecitabine—colon cancer	0.00377	0.00394	CcSEcCtD
Metipranolol—Nausea—Capecitabine—colon cancer	0.00357	0.00373	CcSEcCtD
Metipranolol—Hypersensitivity—Methotrexate—colon cancer	0.0033	0.00345	CcSEcCtD
Metipranolol—Asthenia—Methotrexate—colon cancer	0.00321	0.00336	CcSEcCtD
Metipranolol—Dizziness—Methotrexate—colon cancer	0.00296	0.0031	CcSEcCtD
Metipranolol—Rash—Methotrexate—colon cancer	0.00282	0.00295	CcSEcCtD
Metipranolol—Dermatitis—Methotrexate—colon cancer	0.00282	0.00295	CcSEcCtD
Metipranolol—Headache—Methotrexate—colon cancer	0.00281	0.00293	CcSEcCtD
Metipranolol—Nausea—Methotrexate—colon cancer	0.00266	0.00278	CcSEcCtD
